222.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$226.06
Offen:
$224.52
24-Stunden-Volumen:
496.74K
Relative Volume:
0.56
Marktkapitalisierung:
$16.82B
Einnahmen:
$2.88B
Nettoeinkommen (Verlust:
$499.60M
KGV:
32.97
EPS:
6.74
Netto-Cashflow:
$321.60M
1W Leistung:
-2.83%
1M Leistung:
-0.16%
6M Leistung:
-28.55%
1J Leistung:
-43.85%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
WST
West Pharmaceutical Services Inc
|
222.20 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
![]()
ISRG
Intuitive Surgical Inc
|
491.84 | 181.97B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
227.50 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
95.77 | 47.37B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
219.94 | 32.31B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
33.75 | 17.31B | 17.28B | 108.00M | 391.00M | 0.20 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
2025-01-08 | Eingeleitet | Citigroup | Buy |
2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
2024-12-12 | Hochstufung | UBS | Neutral → Buy |
2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
2022-11-30 | Eingeleitet | UBS | Neutral |
2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
2019-04-23 | Eingeleitet | William Blair | Outperform |
2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2018-01-24 | Eingeleitet | Goldman | Neutral |
2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
2010-05-14 | Bestätigt | UBS | Neutral |
2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India
Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com
Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - Marketscreener.com
Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - BioProcess Online
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire
On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR
Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Announces Leadership Transition - TipRanks
Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online
Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN
Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World
Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance
FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St
West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com
West to Participate in Upcoming Investor Conferences - Quantisnow
West Pharmaceutical Sets Key Investor Conference ScheduleHow to Access Their March Presentations - StockTitan
Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Achieving EU GMP Annex 1 Compliance Through An End-To-End Approach To Contamination Control - Med Device Online
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MSN
West Pharmaceutical Services: How GLP-1 and Biologics Are Unlocking Explosive Growth! - Smartkarma
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):